(Q44359164)

2 December 2017

0 references

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users (English)

1 reference

2 December 2017

0 references

R Thomasius

1

1 reference

2 December 2017

K Petersen

2

1 reference

2 December 2017

R Buchert

3

1 reference

2 December 2017

B Andresen

4

1 reference

2 December 2017

P Zapletalova

5

1 reference

2 December 2017

L Wartberg

6

1 reference

2 December 2017

B Nebeling

7

1 reference

2 December 2017

A Schmoldt

8

1 reference

2 December 2017

publication date

11 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

167

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

85-96

1 reference

Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Memory impairment in abstinent MDMA ("Ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Trends in activity-limiting chronic conditions among children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Auditory verbal learning in drug-free Ecstasy polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Mood state and brain electric activity in ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Is the use of ecstasy and hallucinogens increasing? Results from a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Increasing MDMA use among college students: results of a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

[11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Positron emission tomography of 5-HT reuptake sites in the human brain with C-11 McN5652 extraction of characteristic images by artificial neural network analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

The use of drugs within the techno party scene in European metropolitan cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1383-9

In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain

21 January 2018

1 reference

12 December 2020

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

1 reference

12 December 2020

In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652

1 reference

12 December 2020

Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results

1 reference

12 December 2020

Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery

1 reference

12 December 2020

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

12 December 2020

High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users

1 reference

12 December 2020

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

12 December 2020

Performance evaluation of the positron scanner ECAT EXACT

1 reference

12 December 2020

Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: assessment of methods

1 reference

12 December 2020

Executive function in abstinent MDMA ('ecstasy') users

1 reference

12 December 2020

An introduction to PET and SPECT neuroreceptor quantification models.

1 reference

12 December 2020

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

1 reference

12 December 2020

Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.

1 reference

12 December 2020

Toxic effect of MDMA on brain serotonin neurons

1 reference

12 December 2020

Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions

1 reference

12 December 2020

Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies

1 reference

12 December 2020

Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans

1 reference

12 December 2020

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652

1 reference

12 December 2020

10.1007/S00213-002-1383-9

Identifiers

DOI

1 reference

2 December 2017

1 reference